These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20053293)

  • 1. Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
    Marfurt J; Smith TA; Hastings IM; Müller I; Sie A; Oa O; Baisor M; Reeder JC; Beck HP; Genton B
    Malar J; 2010 Jan; 9():8. PubMed ID: 20053293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology.
    Ballif M; Hii J; Marfurt J; Crameri A; Fafale A; Felger I; Beck HP; Genton B
    Malar J; 2010 Oct; 9():270. PubMed ID: 20925934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
    Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
    Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
    Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
    Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.
    Marfurt J; Müller I; Sie A; Oa O; Reeder JC; Smith TA; Beck HP; Genton B
    Malar J; 2008 Apr; 7():61. PubMed ID: 18423045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
    Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
    Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
    Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B
    Malar J; 2012 Jun; 11():197. PubMed ID: 22694921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.
    Gadalla NB; Abdallah TM; Atwal S; Sutherland CJ; Adam I
    Malar J; 2013 Jul; 12():255. PubMed ID: 23870667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.
    Ogouyèmi-Hounto A; Ndam NT; Fadégnon G; Azagnandji C; Bello M; Moussiliou A; Chippaux JP; Kinde Gazard D; Massougbodji A
    Malar J; 2013 Nov; 12():413. PubMed ID: 24225351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.
    Mubjer RA; Adeel AA; Chance ML; Hassan AA
    Malar J; 2011 Aug; 10():245. PubMed ID: 21854642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
    Tekete M; Djimde AA; Beavogui AH; Maiga H; Sagara I; Fofana B; Ouologuem D; Dama S; Kone A; Dembele D; Wele M; Dicko A; Doumbo OK
    Malar J; 2009 Feb; 8():34. PubMed ID: 19245687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
    Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
    Myers-Hansen JL; Abuaku B; Oyebola MK; Mensah BA; Ahorlu C; Wilson MD; Awandare G; Koram KA; Ngwa AA; Ghansah A
    PLoS One; 2020; 15(12):e0233478. PubMed ID: 33284800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.
    Guerra M; Neres R; Salgueiro P; Mendes C; Ndong-Mabale N; Berzosa P; de Sousa B; Arez AP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
    Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
    Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy.
    Ogouyèmi-Hounto A; Ndam NT; Kinde Gazard D; d'Almeida S; Koussihoude L; Ollo E; Azagnandji C; Bello M; Chippaux JP; Massougbodji A
    Malar J; 2013 May; 12():147. PubMed ID: 23634705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.